July 3, 2025 Newswires

Research Study Findings from Sendero Health Plans Inc. Update Understanding of COVID-19 [Perceptions of the safety, development, and approval process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines among individuals with …]: Coronavirus – COVID-19

Vaccine Daily

2025 JUL 03 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Daily -- Current study results on COVID-19 have been published. According to news originating from Austin, Texas, by NewsRx correspondents, research stated, “Sendero Health Plans, an Affordable Care Act (ACA) health insurance company, conducted a cross-sectional survey in December 2020 to assess individual perceptions of the COVID-19 vaccine development and approval processes and their plan to obtain the COVID-19 vaccine in Central Texas at the time of initial availability.”

Our news reporters obtained a quote from the research from Sendero Health Plans Inc.: “A logistic regression model was developed to identify factors associated with individual plans to obtain a vaccine when it became available. A total of 500 (77.25%) of the 645 respondents in this analysis planned to obtain a COVID-19 vaccine when it became available. The logistic regression model was statistically significant [ch2(19) = 314.41, p < 0.001]. Plans to obtain a COVID-19 vaccine were significantly associated with perceptions of vaccine safety (POR: 23.45, p = 0.001, 95% CI: 3.10, 58.34), vaccine protectiveness (POR: 15.55, p < 0.001, 95% CI: 3.55, 68.06), and transparency of the authorization process (POR: 1.33, p = 0.024, 95% CI: 1.15, 7.15). Perceptions regarding the safety, protectiveness, and authorization process of the COVID-19 vaccines are associated with individual plans to obtain the vaccines.”

According to the news editors, the research concluded: “This study provides insights into factors that influence vaccination intent and key barriers affecting vaccine hesitancy during a public health crisis.”

For more information on this research see: Perceptions of the safety, development, and approval process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines among individuals with Affordable Care Act health insurance in Central Texas at the time of initial vaccine availability. Frontiers in Public Health, 2025,13. (Frontiers in Public Health - http://journal.frontiersin.org/journal/public-health). The publisher for Frontiers in Public Health is Frontiers Media S.A.

A free version of this journal article is available at https://doi.org/10.3389/fpubh.2025.1446984.

Our news journalists report that more information may be obtained by contacting Carlos Lopez Bray, Office of Population Health, Sendero Health Plans Inc., Austin, TX, United States. Additional authors for this research include Richard Taylor, Naomi Tamez, Wesley Durkalski, John R. Litaker.